The following is a summary of the Perimeter Medical Imaging AI, Inc. (PYNKF) Q4 2023 Earnings Call Transcript:

Financial Performance:

• Perimeter Medical Imaging AI ended the year 2023 with approximately $14 million in cash and cash equivalents, ensuring all current product development and clinical operations continue as planned within the existing financial framework.

Business Progress:

• 2023 marked substantial progresses in Perimeter's product development and team morale enhancement, boosted by new leadership and additional resources for the sales team.

• The Perimeter S-Series OCT device user base keeps expanding, contributing to the firm's commercialization progress. This technology provides surgeons with real-time, high-resolution imaging assessments when in operation.

• The product line was further enhanced with the advancement of the B-Series device, which merges OCT with ImgAssist AI technology. This improved deep learning model has shown substantial results in identifying positive margins in breast cancer surgeries, indicating potential to reduce reoperation rates.

• Perimeter has seen expansion in its clinical trial sites, enrolling more patients than first projected.

• The company's future plans include expansion of reference sites, broadening the installed base, and maintaining AI and MedTech improvements.

More details: PERIMETER MEDICAL IMAGING AI INC IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.